Zhejiang Jiuzhou Pharm Co Ltd Financial Flexibility Index
Zhejiang Jiuzhou Pharm Co Ltd financial flexibility index. Zhejiang Jiuzhou Pharm Co Ltd (603456) has a Financial Flexibility Index of 0.34x as of September 2025. Free cash flow of CN¥644.03 Million (operating CF CN¥496.86 Million minus capex CN¥147.17 Million) represents 0% of total liabilities (CN¥1.89 Billion). See 603456 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang Jiuzhou Pharm Co Ltd (2008–2025)
Financial flexibility index of Zhejiang Jiuzhou Pharm Co Ltd from 2008 to 2025. Historical Financial Flexibility Index trend for Zhejiang Jiuzhou Pharm Co Ltd across 18 annual periods. Check how high is Zhejiang Jiuzhou Pharm Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Jiuzhou Pharm Co Ltd Financial Flexibility Index by Year (2008–2025)
Zhejiang Jiuzhou Pharm Co Ltd financial flexibility index by year from 2008 to 2025. Year-by-year free cash flow to debt coverage for Zhejiang Jiuzhou Pharm Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Zhejiang Jiuzhou Pharm Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.37x | CN¥2.48 Billion | CN¥1.82 Billion | CN¥1.81 Billion | ▲ +83.5% |
| 2024 | 0.75x | CN¥1.88 Billion | CN¥991.66 Million | CN¥2.52 Billion | ▼ -24.4% |
| 2023 | 0.99x | CN¥2.29 Billion | CN¥1.36 Billion | CN¥2.32 Billion | ▲ +29.4% |
| 2022 | 0.76x | CN¥1.94 Billion | CN¥1.23 Billion | CN¥2.54 Billion | ▲ +49.5% |
| 2021 | 0.51x | CN¥1.26 Billion | CN¥677.52 Million | CN¥2.46 Billion | ▲ +36.6% |
| 2020 | 0.37x | CN¥716.12 Million | CN¥400.39 Million | CN¥1.92 Billion | ▼ -22.6% |
| 2019 | 0.48x | CN¥874.61 Million | CN¥554.16 Million | CN¥1.81 Billion | ▼ -48.7% |
| 2018 | 0.94x | CN¥495.44 Million | CN¥264.78 Million | CN¥526.81 Million | ▲ +6.4% |
| 2017 | 0.88x | CN¥408.09 Million | CN¥244.20 Million | CN¥461.77 Million | ▲ +35.3% |
| 2016 | 0.65x | CN¥282.11 Million | CN¥136.65 Million | CN¥432.01 Million | ▲ +21.4% |
| 2015 | 0.54x | CN¥440.73 Million | CN¥140.53 Million | CN¥819.46 Million | ▲ +25.8% |
| 2014 | 0.43x | CN¥267.30 Million | CN¥10.17 Million | CN¥624.98 Million | ▲ +7.0% |
| 2013 | 0.40x | CN¥325.61 Million | CN¥203.86 Million | CN¥814.26 Million | ▼ -4.9% |
| 2012 | 0.42x | CN¥313.68 Million | CN¥154.28 Million | CN¥746.26 Million | ▼ -12.2% |
| 2011 | 0.48x | CN¥312.64 Million | CN¥111.01 Million | CN¥653.04 Million | ▼ -5.7% |
| 2010 | 0.51x | CN¥259.85 Million | CN¥105.30 Million | CN¥512.03 Million | ▲ +20.5% |
| 2009 | 0.42x | CN¥163.58 Million | CN¥122.03 Million | CN¥388.45 Million | ▲ +41.0% |
| 2008 | 0.30x | CN¥122.81 Million | CN¥82.84 Million | CN¥411.27 Million | — |